Boston University Chobanian & Avedisian School of Medicine
Boston University Chobanian & Avedisian School of Medicine is a nonprofit academic medical institution founded in 1848 that delivers MD and graduate medical education to nearly 3,800 students, conducts biomedical research through facilities including NEIDL and the Framingham Heart Study, and provides clinical training via Boston Medical Center with a focus on underserved populations.
- Company typePrivate
- Founded1848
- HeadquartersBoston, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Boston University Chobanian & Avedisian School of Medicine does
Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution founded in 1848 as New England's first medical school, operating within Boston University's Medical Campus in the historic South End of Boston. The school delivers medical education through MD and graduate programs (Graduate Medical Sciences), trains nearly 3,800 students, and employs 2,900+ full-time, part-time, affiliate, and volunteer faculty. Its research portfolio is anchored by flagship facilities including the National Emerging Infectious Diseases Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), a cryoEM facility equipped with a Glacios-2 system, and the Framingham Heart Study, the nation's longest-running cardiovascular cohort study at 75+ years. Boston Medical Center, the school's primary teaching affiliate and a safety-net hospital, provides clinical training sites and serves as the main venue for community health service delivery focused on underserved populations.
The school's revenue model is multi-stream and characteristic of nonprofit academic medical centers: (1) tuition and fees from MD and graduate programs billed annually with financial aid support; (2) federal research funding, predominantly from NIH grants supporting work in Alzheimer's genetics, infectious diseases, and other areas; and (3) clinical care revenue flowing through Boston Medical Center as the primary teaching affiliate. The institution has secured major grant funding including a $13.7M NIH award for Alzheimer's genetic research and a $3.9M NIH grant for Alzheimer's therapeutics. A landmark $100 million naming gift from alumnus Edward Avedisian in 2022, the largest in school history, expanded endowed professorships, financial aid, and research initiatives. The school's go-to-market is direct-to-consumer in education (admissions-based enrollment) and enterprise in research (federal grants and institutional collaborations), with clinical services distributed through Boston Medical Center and affiliated community health centers including Codman Square Health Center and DotHouse Health.
The institution is led by a faculty of internationally recognized researchers, including Nobel laureate Drew Weissman (mRNA technology, 2023 Nobel Prize in Physiology or Medicine) as an alumnus and Nancy Sullivan (Ebola vaccine pioneer) as director of NEIDL. Recent strategic leadership appointments include Donald M. Lloyd-Jones as Framingham Heart Study director, Robert A. Davey as NEIDL director, and Alik Farber as Surgeon-in-Chief at Boston Medical Center. Partnerships span Boston Medical Center (primary teaching affiliate), Solomon Carter Fuller Mental Health Center (psychiatry training), Harvard's Countway Library, and the Boston Library Consortium. International research collaborations extend to Israel and other geographies for genetic and epidemiological studies.
Boston University Chobanian & Avedisian School of Medicine firmographics
Firmographics- Name
- Boston University Chobanian & Avedisian School of Medicine
- Legal name
- Boston University Chobanian & Avedisian School of Medicine
- Website
- https://bumc.bu.edu
- Company type
- Private
- Founded year
- 1848
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Boston University Chobanian & Avedisian School of Medicine is a nonprofit academic medical institution founded in 1848 that delivers MD and graduate medical education to nearly 3,800 students, conducts biomedical research through facilities including NEIDL and the Framingham Heart Study, and provides clinical training via Boston Medical Center with a focus on underserved populations.
- Ownership category
- akta.pro rank
Boston University Chobanian & Avedisian School of Medicine industry classification
Industry- Product category
- Medical Education and Academic Medicine
- NAICS
- Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (62211)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Medical Schools (MD/DO Granting) (EDAHAGAB)
- akta.pro secondary industries
- Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Schools of Public Health (EDAHAGAD)
Keywords
Where Boston University Chobanian & Avedisian School of Medicine is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Boston University Chobanian & Avedisian School of Medicine business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Revenue model
- Medical Education Programs: Revenue from tuition and fees for MD, graduate, and professional programs in medicine and health sciences.
- Research Grants and Funding: Federal research funding from NIH for various research initiatives including Alzheimer's disease studies, genetics research, and infectious disease work at NEIDL.
- Clinical Care Revenue: Revenue generated through clinical services at Boston Medical Center, the primary teaching affiliate, including patient care, procedures, and medical services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Medical education programs with varying tuition based on program type and student status |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Boston University Chobanian & Avedisian School of Medicine product offering
Product offeringCore offering
Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution that delivers MD and Graduate Medical Sciences degree programs, postdoctoral research training, and clinical medical education. The school conducts biomedical research through facilities such as NEIDL and the Framingham Heart Study, and provides clinical training at its primary teaching affiliate, Boston Medical Center. Its mission centers on serving disadvantaged, underserved, and indigent populations.
Product overview
Boston University Chobanian & Avedisian School of Medicine is an academic medical institution that provides medical education, research programs, and clinical training through its MD program, Graduate Medical Sciences division, and affiliated teaching hospital Boston Medical Center. The school offers various academic programs across multiple disciplines including medicine, public health, and dental medicine, as part of the larger Boston University Medical Campus. No distinct branded products, modules, or technology platforms with product names were identified in the source data.
Differentiator
Problem solved
Functional benefit
Products and services
- MD Degree Program Four-year medical degree program providing medical education and clinical training for prospective physicians, with clinical rotations at Boston Medical Center.
- Graduate Medical Sciences (GMS) Programs Master's and PhD degree programs in biomedical sciences for graduate students seeking research training and academic career development.
- Clinical Training at Boston Medical Center Clinical residency and clerkship training at Boston Medical Center for medical students, residents, and fellows across multiple specialties.
- Framingham Heart Study Research Program Longitudinal cardiovascular epidemiology research program based on the Framingham Heart Study cohort, providing data and findings on heart disease risk factors.
- National Emerging Infectious Diseases Laboratories (NEIDL) Research Infectious disease research program housed in BSL-4-capable facilities, conducting work on Ebola, virus-host interactions, and antiviral drug discovery.
- Alumni Medical Library Services Library and information services providing access to 6,800+ e-journals, 12,600+ e-books, 25,000+ books, databases, and reference/research support for students, faculty, and staff.
Quantifiable outcome
- Discovery of first vaccine to protect primates from Ebola virus
- +2 more outcomes
Companies that use Boston University Chobanian & Avedisian School of Medicine
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Boston University Chobanian & Avedisian School of Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Boston University Chobanian & Avedisian School of Medicine partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Boston Medical CentercoreBoston Medical Center serves as the primary teaching affiliate of the Chobanian & Avedisian School of Medicine, providing clinical training sites for medical students and residents, and is the main venue for patient care education and community health service delivery.
- Solomon Carter Fuller Mental Health CentercoreState mental health facility that serves as a training site for psychiatry and mental health education, part of the Boston Medical Campus ecosystem.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Boston University Chobanian & Avedisian School of Medicine competitors and assessment
Company assessmentDirect peers
- Harvard Medical School: Elite private medical school in Boston offering MD, PhD, and residency training with extensive NIH funding and a network of major teaching hospitals (MGH, Brigham and Women's). Direct geographic and structural peer of BU Chobanian & Avedisian.
- Tufts University School of Medicine: Private Boston-area medical school with a comparable MD program, Graduate Biomedical Sciences division, and public-health orientation. Competes with BU for the same applicant pool and clinical training affiliates.
- Brown University Warren Alpert Medical School: Private Ivy League medical school in the Northeast offering an MD program with significant NIH-funded biomedical research. Comparable in scale, mission, and applicant demographic to BU.
- Yale School of Medicine: Top-tier private research medical school with strong NIH funding and Yale New Haven Hospital as primary teaching affiliate. Direct competitor for faculty recruitment and biomedical research grants.
- Columbia University Vagelos College of Physicians and Surgeons: Private research-intensive medical school in NYC with similar NIH-funded research scale, MD/PhD programs, and a major urban teaching hospital affiliate. Comparable in research output and applicant profile.
- NYU Grossman School of Medicine: Private NYC medical school that pioneered fully-funded tuition, attracting top applicants. Direct competitor for MD enrollment and operates NYU Langone as its primary teaching affiliate — a structural parallel to BU/BMC.
- Weill Cornell Medicine: Private NYC medical school affiliated with Cornell University and NewYork-Presbyterian Hospital. Comparable in NIH funding scale, research portfolio, and MD/PhD program structure.
- University of Pennsylvania Perelman School of Medicine: Top-5 private research medical school with massive NIH funding, a large faculty, and Penn Medicine as integrated health system. Comparable in research intensity and biomedical graduate training scale.
- Johns Hopkins University School of Medicine: Top-tier private research medical school consistently #1 in NIH funding, with Johns Hopkins Hospital as primary teaching affiliate. Direct peer in research output, MD/PhD training, and biomedical discovery leadership.
Others
- Boston Medical Center: Primary teaching affiliate of BU Chobanian & Avedisian School of Medicine and a major safety-net hospital. While not a peer medical school, it is the principal clinical training site and the operational anchor for the school's clinical mission.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Boston University Chobanian & Avedisian School of Medicine social profiles
Digital presenceBoston University Chobanian & Avedisian School of Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Boston University Chobanian & Avedisian School of Medicine leadership team
Management profileNumber of profiles
Profiles5 records
Boston University Chobanian & Avedisian School of Medicine subsidiaries and ownership
Company hierarchySubsidiaries3 records
Boston University Chobanian & Avedisian School of Medicine funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Boston University Chobanian & Avedisian School of Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Boston University Chobanian & Avedisian School of Medicine
What does Boston University Chobanian & Avedisian School of Medicine do?
Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution that delivers MD and Graduate Medical Sciences degree programs, postdoctoral research training, and clinical medical education. The school conducts biomedical research through facilities such as NEIDL and the Framingham Heart Study, and provides clinical training at its primary teaching affiliate, Boston Medical Center. Its mission centers on serving disadvantaged, underserved, and indigent populations.
Is Boston University Chobanian & Avedisian School of Medicine a public or private company?
Boston University Chobanian & Avedisian School of Medicine is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Boston University Chobanian & Avedisian School of Medicine founded?
Boston University Chobanian & Avedisian School of Medicine was founded in 1848. It employs 5,001 to 10,000 people.
Where is Boston University Chobanian & Avedisian School of Medicine based?
Boston University Chobanian & Avedisian School of Medicine is headquartered in Boston, United States, in the North America region.
How does Boston University Chobanian & Avedisian School of Medicine make money?
Three revenue lines are on record. Medical Education Programs are the primary driver. The others are research Grants and Funding and clinical Care Revenue.
Who are Boston University Chobanian & Avedisian School of Medicine's main competitors?
Direct peers on record are Harvard Medical School, Tufts University School of Medicine, Brown University Warren Alpert Medical School, Yale School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, NYU Grossman School of Medicine, Weill Cornell Medicine, University of Pennsylvania Perelman School of Medicine and Johns Hopkins University School of Medicine. Boston Medical Center is listed as an others.
Does Boston University Chobanian & Avedisian School of Medicine have an API?
No public API is recorded for Boston University Chobanian & Avedisian School of Medicine.
What industry is Boston University Chobanian & Avedisian School of Medicine in?
Boston University Chobanian & Avedisian School of Medicine's product category is Medical Education and Academic Medicine. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 6113 and its SIC code is 8060.